BR112023000167A2 - Terapia de náusea e vômito pós-operatórios - Google Patents

Terapia de náusea e vômito pós-operatórios

Info

Publication number
BR112023000167A2
BR112023000167A2 BR112023000167A BR112023000167A BR112023000167A2 BR 112023000167 A2 BR112023000167 A2 BR 112023000167A2 BR 112023000167 A BR112023000167 A BR 112023000167A BR 112023000167 A BR112023000167 A BR 112023000167A BR 112023000167 A2 BR112023000167 A2 BR 112023000167A2
Authority
BR
Brazil
Prior art keywords
vomiting
therapy
post
operative nausea
patient
Prior art date
Application number
BR112023000167A
Other languages
English (en)
Portuguese (pt)
Inventor
Clive Gilbert Julian
Fox Gabriel
William Gristwood Robert
Original Assignee
Acacia Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB2010361.0A external-priority patent/GB202010361D0/en
Priority claimed from GBGB2108238.3A external-priority patent/GB202108238D0/en
Application filed by Acacia Pharma Ltd filed Critical Acacia Pharma Ltd
Publication of BR112023000167A2 publication Critical patent/BR112023000167A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112023000167A 2020-07-06 2021-07-06 Terapia de náusea e vômito pós-operatórios BR112023000167A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2010361.0A GB202010361D0 (en) 2020-07-06 2020-07-06 Therapy of post-operative nausea and vomiting
GBGB2108238.3A GB202108238D0 (en) 2021-06-09 2021-06-09 Thearpy of post-operative nausea and vomiting
PCT/GB2021/051720 WO2022008901A1 (en) 2020-07-06 2021-07-06 Therapy of post-operative nausea and vomiting

Publications (1)

Publication Number Publication Date
BR112023000167A2 true BR112023000167A2 (pt) 2023-01-31

Family

ID=77021661

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023000167A BR112023000167A2 (pt) 2020-07-06 2021-07-06 Terapia de náusea e vômito pós-operatórios

Country Status (11)

Country Link
US (1) US20230263770A1 (https=)
EP (1) EP4175631A1 (https=)
JP (1) JP2023538216A (https=)
KR (1) KR20230035095A (https=)
CN (1) CN115867271A (https=)
AU (1) AU2021305446A1 (https=)
BR (1) BR112023000167A2 (https=)
CA (1) CA3187665A1 (https=)
IL (1) IL299649A (https=)
MX (1) MX2023000283A (https=)
WO (1) WO2022008901A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250152595A1 (en) * 2023-11-09 2025-05-15 Lisa Myslinski Medication to alleviate nausea with or without vomiting, vertigo, and pain

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201004020D0 (en) 2010-03-11 2010-04-21 Acacia Pharma Ltd New therapeutic use
GB201618425D0 (en) * 2016-11-01 2016-12-14 Acacia Pharma Ltd method
GB201702250D0 (en) * 2017-02-10 2017-03-29 Acacia Pharma Ltd Method

Also Published As

Publication number Publication date
CN115867271A (zh) 2023-03-28
CA3187665A1 (en) 2022-01-13
US20230263770A1 (en) 2023-08-24
JP2023538216A (ja) 2023-09-07
EP4175631A1 (en) 2023-05-10
AU2021305446A1 (en) 2023-02-02
MX2023000283A (es) 2023-02-09
KR20230035095A (ko) 2023-03-10
WO2022008901A1 (en) 2022-01-13
IL299649A (en) 2023-03-01

Similar Documents

Publication Publication Date Title
WO2009129210A3 (en) Compositions and methods for treating post-operative pain using clonidine and bupivacaine
BR0110815A (pt) Membro de alinhamento colocação de um dispositivo não simétrico com uma orientação predefinida
BRPI0317817A2 (pt) dispositivo e disposição para instalação de implante
PT756483E (pt) Uso de bisfosfonatos para inibir a reabsorcao ossea a seguir a implantacao de proteses ortopedicas
BRPI0810555B8 (pt) implante dentário
EP1762271A3 (en) Rehydration composition
BR112023000167A2 (pt) Terapia de náusea e vômito pós-operatórios
BR112012007564A2 (pt) sistema cirúrgico para posicionar componente protético e/ou para restringir movimento de ferramenta cirúrgica
DE602005022976D1 (de) Gerät, um einen orthopädischen Eingriff sprachgesteuert durchzuführen
BRPI0504202A (pt) haste endomedular e dispositivo para o tratamento de fraturas proximais do fêmur
BRPI0507628A (pt) composto ou sal farmaceuticamente aceitável do mesmo, método de tratamento de uma infecção viral em um ser humano, uso de um composto composição farmacêutica, e, processo para a preparação de um composto
EP1377245A4 (en) IMMUNOSTIMULATING COATING FOR SURGICAL DEVICES
BR112020020131A8 (pt) Mistura antidegradante, uso da mesma e artigo útil
BR112022025911A2 (pt) Combinação de um inibidor de bromodomínio de cbp/p300 e um inibidor de egfr para uso no tratamento de um cpcnp com egfr mutante
BR112023016682A2 (pt) Terapia de combinação de obicetrapibe e ezetimiba para uso em pacientes intolerantes a estatina sofrendo de hiperlipidemia ou dislipidemia mista
NO20000446D0 (no) Anvendelse av fysiologisk akseptable vanadiumforbindelser, salter og komplekser
BR102018068947A8 (pt) sistemas de instrumento cirúrgico ortopédico específicos para um lado do corpo e métodos de uso associados
BR0309757A (pt) 6-alquilideno-penemas bicìclicos como inibidores de beta-lactamases
WO2023159152A3 (en) Combination therapy of lilrb antagonist and pd-1/pd-l1 axis inhibitor
Hewitt et al. Flexion vs. extension: a comparison of post-operative total knee arthroplasty mobilisation regimes
ZA202306279B (en) Therapy of post-operative emesis with amisulpride
WO2007122623A3 (en) Device for stable spatial fixation and central drilling with distal interlocking screws in limb procedures
BR0308591A (pt) Produto de campo cirúrgico tendo uma borda adesiva para intervenções cirúrgicas
BR0215389A (pt) Agente preventivo ou terapêutico para distúrbio urinário, método para prevenir ou tratar distúrbio urinário, uso de um composto, composto, pró-droga, processo para preparar o composto, medicamento, e, método para triar um composto
PT1156805E (pt) Utilizacao de sistenas piliciclicos de tiazole para a fabricacao de medicamentospara a profilaxia ou o tratamento de obesidade